NCT03825250View on ClinicalTrials.gov

The Val-CARD Trial

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

November 6, 2018

Primary Completion Date

October 7, 2024

Study Completion Date

October 7, 2024

Conditions
Cardiac Valve DiseaseCoronary Artery DiseaseOrgan Failure, Multiple
Interventions
DRUG

Sodium Valproate

Treatment with Sodium Valproate vs. Control Discovery phase - 4 arms: 15 mg/kg for 1-2 weeks; 15mg/kg for 4-6 weeks; 25 mg/kg for 4-6 weeks; Control Efficiency phase - 2 arms: Treatment group selected from previous phase; Control

Trial Locations (1)

LE3 9QP

RECRUITING

Glenfield Hospital, Leicester

All Listed Sponsors
lead

University of Leicester

OTHER